accountin the past two years to diversify sales ahead of Humira's patent expiration in 2017. Last week Pfizer Inc. reported results for its experimental drug tofacitinib in reducing damage caused by rheumatoid arthritis. Some analysts have speculated that the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott 1Q profit beats estimates on higher sales
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account